Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Archives of Gynecology and Obstetrics
|
June 5, 2024
Has the name PCOS run its course?
Samuel H Myers, Gianpiero Forte, Vittorio Unfer
Archives of Gynecology and Obstetrics
|
July 8, 2024
Correction: Has the name PCOS run its course?
Samuel H Myers, Gianpiero Forte, Vittorio Unfer
Chemistry & Biodiversity
|
August 1, 2024
Bisphenol A in Water Systems: Risks to Polycystic Ovary Syndrome and Biochar-Based Adsorption Remediation: A Review
Cinzia Michenzi, Samuel H Myers, Isabella Chiarotto
Journal of Medicinal Chemistry
|
November 2, 2020
Synthetic Lethality through the Lens of Medicinal Chemistry
Samuel H Myers, Jose Antonio Ortega, Andrea Cavalli
Gynecologic and Obstetric Investigation
|
March 20, 2025
Endocrine Metabolic Syndrome and Metabolic Syndrome: Distinct but Interrelated Pathologies
Samuel H Myers, Christophe O Soulage, Vittorio Unfer
Journal of Medicinal Chemistry
|
November 12, 2015
AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective
Samuel H Myers, Valerie G Brunton, Asier Unciti-Broceta
Gynecologic and Obstetric Investigation
|
January 31, 2024
The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria
Olga Pustotina, Samuel H Myers, Vittorio Unfer, et al.
Archives of Gynecology and Obstetrics
|
March 19, 2024
PCOS phenotype focus: phenotype D under the magnifying glass
Samuel H Myers, Mario Montanino Oliva, Maurizio Nordio, et al.
Frontiers in Endocrinology
|
March 13, 2025
Corrigendum: Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS
Paola Quaresima, Samuel H Myers, Basilio Pintaudi, et al.
Bioorganic & Medicinal Chemistry
|
December 3, 2019
Pyrazolopyrimide library screening in glioma cells discovers highly potent antiproliferative leads that target the PI3K/mTOR pathway
Teresa Valero, Daniel J Baillache, Craig Fraser, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Archives of Gynecology and Obstetrics
|
June 5, 2024
Has the name PCOS run its course?
Samuel H Myers, Gianpiero Forte, Vittorio Unfer
Archives of Gynecology and Obstetrics
|
July 8, 2024
Correction: Has the name PCOS run its course?
Samuel H Myers, Gianpiero Forte, Vittorio Unfer
Chemistry & Biodiversity
|
August 1, 2024
Bisphenol A in Water Systems: Risks to Polycystic Ovary Syndrome and Biochar-Based Adsorption Remediation: A Review
Cinzia Michenzi, Samuel H Myers, Isabella Chiarotto
Journal of Medicinal Chemistry
|
November 2, 2020
Synthetic Lethality through the Lens of Medicinal Chemistry
Samuel H Myers, Jose Antonio Ortega, Andrea Cavalli
Gynecologic and Obstetric Investigation
|
March 20, 2025
Endocrine Metabolic Syndrome and Metabolic Syndrome: Distinct but Interrelated Pathologies
Samuel H Myers, Christophe O Soulage, Vittorio Unfer
Journal of Medicinal Chemistry
|
November 12, 2015
AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective
Samuel H Myers, Valerie G Brunton, Asier Unciti-Broceta
Gynecologic and Obstetric Investigation
|
January 31, 2024
The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria
Olga Pustotina, Samuel H Myers, Vittorio Unfer, et al.
Archives of Gynecology and Obstetrics
|
March 19, 2024
PCOS phenotype focus: phenotype D under the magnifying glass
Samuel H Myers, Mario Montanino Oliva, Maurizio Nordio, et al.
Frontiers in Endocrinology
|
March 13, 2025
Corrigendum: Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS
Paola Quaresima, Samuel H Myers, Basilio Pintaudi, et al.
Bioorganic & Medicinal Chemistry
|
December 3, 2019
Pyrazolopyrimide library screening in glioma cells discovers highly potent antiproliferative leads that target the PI3K/mTOR pathway
Teresa Valero, Daniel J Baillache, Craig Fraser, et al.
Page
of 3